Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
MP3 Pilot
Z 31901 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women: A Pilot Study
2 other identifiers
interventional
341
1 country
1
Brief Summary
The overall objective of this study is to evaluate whether the addition of secondary distribution HIV self-test kits to existing partner notification guidelines increases the proportion of male partners who access facility-based HIV testing services, when compared to the partner notification strategy alone
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Sep 2019
Shorter than P25 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2019
CompletedFirst Submitted
Initial submission to the registry
October 9, 2019
CompletedFirst Posted
Study publicly available on registry
October 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2020
CompletedResults Posted
Study results publicly available
May 24, 2021
CompletedJuly 21, 2021
April 1, 2021
10 months
October 9, 2019
April 29, 2021
June 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Reported Primary Male Partner Completed HIV Testing at a Healthcare Facility
The number of participants who report their primary male partners getting tested for HIV at a healthcare facility when presented with partner notification plus secondary distribution of HIV self-test kits compared to partner notification alone
Enrollment - 30 days post enrollment of study participant
Secondary Outcomes (4)
Number of Participants Who Reported HIV Testing With Primary Male Partner at a Healthcare Facility
Enrollment - 30 days post enrollment of study participant
Number of Participants Reporting Social Harms
Enrollment - 30 days post enrollment of study participant
Number of Healthcare Providers Describing Feasibility of Intervention Via In-depth Interviews (Qualitative)
6 months after the start of enrollment
Number of Participants Describing Acceptability of Intervention Via In-depth Interviews (Qualitative)
In the first two months of enrollment
Other Outcomes (1)
Number of Participants Who Reported Primary Male Partner HIV Testing Completed at Any Venue
Enrollment - 30 days post enrollment of study participant
Study Arms (2)
Intervention
EXPERIMENTALIn addition to standard partner notification services, the intervention arm will receive HIV self-test kits and structured counseling about HIVST, regardless of HIV status.
Control
NO INTERVENTIONStandard partner notification services, regardless of HIV status.
Interventions
HIV self-test kits are oral swabs. Partner notification will be offered to all women in the intervention arm, regardless of HIV status.
Eligibility Criteria
You may qualify if:
- years of age or older
- Pregnant at time of enrollment based on antenatal record
- Documented HIV status (either positive or negative) in antenatal record
- Reports at least one current sexual partner
- Willingness to provide her own contact information
- Ability and willingness to provide informed consent
- Intent to remain in current geographical area of residence for the duration of follow-up activities
- Willingness to adhere to study procedures
You may not qualify if:
- Women who express concerns about IPV or social harms as a result of participation during the screening process will not be included.
- Women who have previously enrolled in the study will not be permitted to enroll again.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chipata Health Centre
Lusaka, Zambia
Related Publications (1)
Mutale W, Freeborn K, Graybill LA, Lusaka MM, Mollan KR, Mweemba O, Kasaro M, Lungu R, Kumwenda A, Saidi F, Powers KA, Maman S, Rosenberg NE, Chi BH. Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials. Lancet Glob Health. 2021 Dec;9(12):e1719-e1729. doi: 10.1016/S2214-109X(21)00393-4. Epub 2021 Nov 1.
PMID: 34735862DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Benjamin Chi, MD, MSc
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Ben Chi, MD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2019
First Posted
October 11, 2019
Study Start
September 3, 2019
Primary Completion
July 3, 2020
Study Completion
September 7, 2020
Last Updated
July 21, 2021
Results First Posted
May 24, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 9 to 36 months following publication
- Access Criteria
- IRB, IEC, or REB approval, as applicable, and an executed data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.